- Home
- Publications
- Publication Search
- Publication Details
Title
Antibody‐mediated phagocytosis in cancer immunotherapy
Authors
Keywords
-
Journal
IMMUNOLOGICAL REVIEWS
Volume 319, Issue 1, Pages 128-141
Publisher
Wiley
Online
2023-08-22
DOI
10.1111/imr.13265
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acalabrutinib and High-Frequency Low-Dose Subcutaneous Rituximab for Initial Therapy of Chronic Lymphocytic Leukemia
- (2023) Danielle S Wallace et al. Blood Advances
- Rituximab induced cytokine release with high serum IP-10 (CXCL10) concentrations is associated with infusion reactions
- (2023) Jeremiah E. Moore et al. LEUKEMIA RESEARCH
- The highly selective Bruton tyrosine kinase inhibitor acalabrutinib leaves macrophage phagocytosis intact
- (2022) Jonathan J. Pinney et al. HAEMATOLOGICA
- Efficacy and safety of new anti-CD20 monoclonal antibodies versus rituximab for induction therapy of CD20+ B-cell non-Hodgkin lymphomas: a systematic review and meta-analysis
- (2021) Chengxin Luo et al. Scientific Reports
- Imaging the mechanisms of anti-CD20 therapy in vivo uncovers spatiotemporal bottlenecks in antibody-dependent phagocytosis
- (2021) Capucine L. Grandjean et al. Science Advances
- Complement Receptors and Their Role in Leukocyte Recruitment and Phagocytosis
- (2021) Sofie Vandendriessche et al. Frontiers in Cell and Developmental Biology
- High-resolution quantification of discrete phagocytic events by live cell time-lapse high-content microscopy imaging
- (2020) Charles C. Chu et al. JOURNAL OF CELL SCIENCE
- Acalabrutinib plus Obinutuzumab in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia
- (2020) Jennifer A. Woyach et al. Cancer Discovery
- Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial
- (2020) Jeff P Sharman et al. LANCET
- DuoHexaBody-CD37®, a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignancies
- (2020) Simone C. Oostindie et al. Blood Cancer Journal
- Macrophage hypophagia as a mechanism of innate immune exhaustion in mAb-induced cell clearance
- (2020) Jonathan J Pinney et al. BLOOD
- The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy
- (2020) Gabriela Pavlasova et al. HAEMATOLOGICA
- Phase II Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia
- (2020) Kerry A. Rogers et al. JOURNAL OF CLINICAL ONCOLOGY
- Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial
- (2020) Othman Al-Sawaf et al. LANCET ONCOLOGY
- CD20 and CD37 antibodies synergize to activate complement by Fc-mediated clustering
- (2019) Simone C. Oostindie et al. HAEMATOLOGICA
- Mechanisms of lymphoma clearance induced by high-dose alkylating agents
- (2019) Chen Lossos et al. Cancer Discovery
- Antibody-Dependent Cellular Phagocytosis by Macrophages is a Novel Mechanism of Action of Elotuzumab
- (2018) Ahmed T. Kurdi et al. MOLECULAR CANCER THERAPEUTICS
- Cellular Cytotoxicity of Next-Generation CD20 Monoclonal Antibodies
- (2018) Karl R. VanDerMeid et al. Cancer Immunology Research
- Immune Checkpoint Inhibition Overcomes ADCP-Induced Immunosuppression by Macrophages
- (2018) Shicheng Su et al. CELL
- CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
- (2018) Ranjana Advani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural Immunology of Complement Receptors 3 and 4
- (2018) Thomas Vorup-Jensen et al. Frontiers in Immunology
- Role for ZAP-70 Signaling in the Differential Effector Functions of Rituximab and Obinutuzumab (GA101) in Chronic Lymphocytic Leukemia B Cells
- (2017) Sladjana Skopelja-Gardner et al. JOURNAL OF IMMUNOLOGY
- Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study
- (2017) John F Seymour et al. LANCET ONCOLOGY
- Affinity of human IgG subclasses to mouse Fc gamma receptors
- (2017) Gillian Dekkers et al. mAbs
- β2 Integrins As Regulators of Dendritic Cell, Monocyte, and Macrophage Function
- (2017) Leonie Schittenhelm et al. Frontiers in Immunology
- Phagocytosis: The Legacy of Metchnikoff
- (2016) Siamon Gordon CELL
- Maxed out macs: physiologic cell clearance as a function of macrophage phagocytic capacity
- (2016) Clive S. Zent et al. FEBS Journal
- Intravital imaging reveals improved Kupffer cell-mediated phagocytosis as a mode of action of glycoengineered anti-CD20 antibodies
- (2016) Capucine L. Grandjean et al. Scientific Reports
- Antibody-Dependent Phagocytosis of Tumor Cells by Macrophages: A Potent Effector Mechanism of Monoclonal Antibody Therapy of Cancer
- (2015) N. Gul et al. CANCER RESEARCH
- Anti-CD20 monoclonal antibody-dependent phagocytosis of chronic lymphocytic leukaemia cells by autologous macrophages
- (2015) A. K. Church et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Of ITIMs, ITAMs, and ITAMis: revisiting immunoglobulin Fc receptor signaling
- (2015) Andrew Getahun et al. IMMUNOLOGICAL REVIEWS
- Fcγ receptor pathways during active and passive immunization
- (2015) Stylianos Bournazos et al. IMMUNOLOGICAL REVIEWS
- Mouse and human FcR effector functions
- (2015) Pierre Bruhns et al. IMMUNOLOGICAL REVIEWS
- Trastuzumab Triggers Phagocytic Killing of High HER2 Cancer Cells In Vitro and In Vivo by Interaction with Fcγ Receptors on Macrophages
- (2015) Yun Shi et al. JOURNAL OF IMMUNOLOGY
- An Fc engineering approach that modulates antibody-dependent cytokine release without altering cell-killing functions
- (2015) Michelle Kinder et al. mAbs
- Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma
- (2015) Marije B Overdijk et al. mAbs
- Phagocytosis of apoptotic cells in homeostasis
- (2015) Sanja Arandjelovic et al. NATURE IMMUNOLOGY
- Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cells
- (2014) Clive S. Zent et al. AMERICAN JOURNAL OF HEMATOLOGY
- Fc -receptor-mediated trogocytosis impacts mAb-based therapies: historical precedence and recent developments
- (2014) R. P. Taylor et al. BLOOD
- Ibrutinib interferes with the cell-mediated anti-tumor activities of therapeutic CD20 antibodies: implications for combination therapy
- (2014) F. D. Roit et al. HAEMATOLOGICA
- Macrophages eliminate circulating tumor cells after monoclonal antibody therapy
- (2014) Nuray Gül et al. JOURNAL OF CLINICAL INVESTIGATION
- Complement Receptor of the Ig Superfamily Enhances Complement-Mediated Phagocytosis in a Subpopulation of Tissue Resident Macrophages
- (2014) N. N. Gorgani et al. JOURNAL OF IMMUNOLOGY
- Experimental Antibody Therapy of Liver Metastases Reveals Functional Redundancy between Fc RI and Fc RIV
- (2014) M. A. Otten et al. JOURNAL OF IMMUNOLOGY
- Comparative Functional Evolution of Human and Mouse CR1 and CR2
- (2014) A. C. Jacobson et al. JOURNAL OF IMMUNOLOGY
- Induced Resistance to Ofatumumab-Mediated Cell Clearance Mechanisms, Including Complement-Dependent Cytotoxicity, in Chronic Lymphocytic Leukemia
- (2014) N. A. Baig et al. JOURNAL OF IMMUNOLOGY
- Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study
- (2014) S E M Herman et al. LEUKEMIA
- Type I and type II Fc receptors regulate innate and adaptive immunity
- (2014) Andrew Pincetic et al. NATURE IMMUNOLOGY
- The mechanism of anti-CD20–mediated B cell depletion revealed by intravital imaging
- (2013) Fabricio Montalvao et al. JOURNAL OF CLINICAL INVESTIGATION
- Properties of mouse and human IgG receptors and their contribution to disease models
- (2012) P. Bruhns BLOOD
- Crosstalk between Human IgG Isotypes and Murine Effector Cells
- (2012) M. B. Overdijk et al. JOURNAL OF IMMUNOLOGY
- Exhaustion of Cytotoxic Effector Systems May Limit Monoclonal Antibody-Based Immunotherapy in Cancer Patients
- (2012) F. J. Beurskens et al. JOURNAL OF IMMUNOLOGY
- The Cell Biology of Phagocytosis
- (2011) Ronald S. Flannagan et al. Annual Review of Pathology-Mechanisms of Disease
- Loss of CD20 and Bound CD20 Antibody from Opsonized B Cells Occurs More Rapidly Because of Trogocytosis Mediated by Fc Receptor-Expressing Effector Cells Than Direct Internalization by the B Cells
- (2011) P. V. Beum et al. JOURNAL OF IMMUNOLOGY
- Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
- (2010) Mark P. Chao et al. CELL
- Mechanism of transfer of immune complexes from red blood cell CR1 to monocytes
- (2010) W. EMLEN et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Receptor mobility, the cytoskeleton, and particle binding during phagocytosis
- (2010) Valentin Jaumouillé et al. CURRENT OPINION IN CELL BIOLOGY
- Experimentally induced liver metastases from colorectal cancer can be prevented by mononuclear phagocyte-mediated monoclonal antibody therapy
- (2010) Gerben J. van der Bij et al. JOURNAL OF HEPATOLOGY
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
- (2010) M Hallek et al. LANCET
- Complement: a key system for immune surveillance and homeostasis
- (2010) Daniel Ricklin et al. NATURE IMMUNOLOGY
- Pancreatitis and atypical Kawasaki disease
- (2010) Dragan Prokic et al. Pediatric Rheumatology
- Complement and its role in innate and adaptive immune responses
- (2009) Jason R Dunkelberger et al. CELL RESEARCH
- Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions
- (2009) Anna Erdei et al. MOLECULAR IMMUNOLOGY
- Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage Fc RI, Fc RIII, and Fc RIV
- (2008) V. Minard-Colin et al. BLOOD
- Specificity and affinity of human Fc receptors and their polymorphic variants for human IgG subclasses
- (2008) P. Bruhns et al. BLOOD
- Macrophages and Fc-receptor interactions contribute to the antitumour activities of the anti-CD40 antibody SGN-40
- (2008) E Oflazoglu et al. BRITISH JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More